Common use of Progressive Scleroderma Clause in Contracts

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood vessels and visceral organs. This diagnosis must be unequivocally supported by biopsy and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following are excluded: • Localised scleroderma (linear scleroderma or morphea); • Eosinophilic fascitis; and • CREST syndrome.

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood vessels and visceral organs. This diagnosis must be unequivocally supported by biopsy and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following conditions are excluded: • Localised scleroderma (linear scleroderma or morphea); • Eosinophilic fascitisEosinophilicfascitis; and • CREST syndrome.

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood vessels and visceral organs. This diagnosis must be unequivocally confirmed by a consultant rheumatologist and supported by biopsy or equivalent confirmatory test, and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following are excluded: • Localised scleroderma (linear scleroderma or morphea); • Eosinophilic fascitis; and • CREST syndrome.

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood vessels and visceral organs. This diagnosis must be unequivocally supported by biopsy and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following conditions are excluded: • Localised scleroderma (linear scleroderma or morphea); • Eosinophilic fascitisEosinophilicfascitis; and • CREST syndrome.and

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood vessels and visceral organs. This diagnosis must be unequivocally supported by biopsy and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following are excluded: •  Localised scleroderma (linear scleroderma or morphea); •  Eosinophilic fascitis; and •  CREST syndrome.

Progressive Scleroderma. A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skintheskin, blood vessels and visceral organs. This diagnosis must be unequivocally supported by biopsy and serological evidence and the disorder must have reached systemic proportions to involve the heart, lungs or kidneys. The following conditions are excluded: • Localised scleroderma (linear scleroderma or morphea); • Eosinophilic fascitisEosinophilicfascitis; and • CREST syndrome.